DocGo Inc. Other Non-Current Assets
DocGo Inc. (DCGO) had Other Non-Current Assets of $3.48 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-17
- 2026-06-30: Other Assets, Noncurrent $3.48M.
- 2026-03-31: Other Assets, Noncurrent $3.34M.
- 2025-12-31: Other Assets, Noncurrent $3.35M.
- 2025-09-30: Other Assets, Noncurrent $3.09M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $3.48M 10-Q · filed 2026-08-17 |
| 2026-03-31 | $3.34M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $3.35M 10-Q · filed 2026-08-17 |
| 2025-09-30 | $3.09M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.15M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $3.58M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.73M 10-K · filed 2026-03-16 |
| 2024-09-30 | $3.43M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.30M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $2.41M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.57M 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.93M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $3.54M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.35M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.63M 10-K · filed 2024-02-28 |
| 2022-09-30 | $3.10M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.68M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.62M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.81M 10-K · filed 2023-03-14 |
| 2020-12-31 | $1.32M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |